Galderma

Galderma is the world's largest independent pure-play dermatology company, developing and delivering science-based skin health solutions across three areas: Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Founded in 1981 and tracing its origins to a joint venture between Nestlé and L'Oréal, the company has spent more than 40 years dedicated to skin health and has been the world's largest independent global dermatology company since 2019. It listed on the SIX Swiss Exchange in 2024.

The company employs more than 7,000 people and operates in approximately 90 countries, reporting net sales of USD 4.410 billion in 2024. Its work spans dermatology, pharmaceuticals, medical aesthetics, skincare and consumer health, and healthcare professional training - areas that call for expertise in injectable aesthetics, therapeutic dermatology, dermatological skincare formulation and aesthetic medicine education.

Beyond its product portfolios, Galderma runs the Global Aesthetic Injector Network, a set of training programmes for aesthetic injectors delivered in partnership with healthcare professionals. The company describes an Integrated Dermatology Strategy as the basis for its growth, with an emphasis on scientific rigour, innovation and collaboration with healthcare professionals across its operations.